These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37013318)

  • 1. Diabetes and severe COVID-19 infection: Connecting the dots.
    Bhattacharya S; Anne B; Tyagi P; Nagendra L; Kalra S
    J Pak Med Assoc; 2022 Nov; 72(11):2332-2334. PubMed ID: 37013318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of COVID-19 pathogenesis in diabetes.
    Aluganti Narasimhulu C; Singla DK
    Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H403-H420. PubMed ID: 35776683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and diabetes-Two giants colliding: From pathophysiology to management.
    Pelle MC; Zaffina I; Provenzano M; Moirano G; Arturi F
    Front Endocrinol (Lausanne); 2022; 13():974540. PubMed ID: 36060943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
    Albini A; Di Guardo G; Noonan DM; Lombardo M
    Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review.
    Das S; K R A; Birangal SR; Nikam AN; Pandey A; Mutalik S; Joseph A
    Life Sci; 2020 Oct; 258():118202. PubMed ID: 32758625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.
    Shah H; Khan MSH; Dhurandhar NV; Hegde V
    Acta Diabetol; 2021 Jul; 58(7):831-843. PubMed ID: 33587177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.
    Suárez-Reyes A; Villegas-Valverde CA
    MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
    Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
    Rajpal A; Rahimi L; Ismail-Beigi F
    J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
    Norooznezhad AH; Mansouri K
    Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention.
    Gęca T; Wojtowicz K; Guzik P; Góra T
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is diabetes mellitus a wrongdoer to COVID-19 severity?
    Sarkar S; Das D; Borsingh Wann S; Kalita J; Manna P
    Diabetes Res Clin Pract; 2021 Aug; 178():108936. PubMed ID: 34217771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives.
    Dalamaga M; Christodoulatos GS; Karampela I; Vallianou N; Apovian CM
    Curr Obes Rep; 2021 Sep; 10(3):214-243. PubMed ID: 33909265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study.
    Íñiguez M; Pérez-Matute P; Villoslada-Blanco P; Recio-Fernandez E; Ezquerro-Pérez D; Alba J; Ferreira-Laso ML; Oteo JA
    Front Endocrinol (Lausanne); 2021; 12():688071. PubMed ID: 34489863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.